Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections
Clinical trial NCT06089044 · COMPLETED
Trial details
- NCT number
- NCT06089044
- Sponsor
- Tourcoing Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.